4
Changes in Ownership
TransMedics Group, Inc. Filed Acc 0000950170-24-016560
Chief Commercial Officer sold 3,826 shares at an average $90.02 ($344,432)
- Chief Commercial Officer acquired 3,826 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Khayal Tamer I · Chief Commercial Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-14 | Exercise or conversion : show line 1 in the form 10b5-1 | +3,050 | $16.00 | $48,800 | 17,425 | D |
| 2024-02-14 | Sale : show line 2 in the form 10b5-1 | −3,050 | $90.03 | $274,592 | 14,375 | D |
| 2024-02-15 | Exercise or conversion : show line 3 in the form 10b5-1 | +776 | $16.00 | $12,416 | 15,151 | D |
| 2024-02-15 | Sale : show line 4 in the form 10b5-1 | −776 | $90.00 | $69,840 | 14,375 | D |
| Open-market sales · 3,826 sh · avg $90.02 · $344,432 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-02-14 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) | −3,050 | 1,920 | D |
| 2024-02-15 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) | −776 | 1,144 | D |
Loading xslF345X05/ownership.xml…